162 related articles for article (PubMed ID: 15530671)
1. Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial.
Nurkka A; Lahdenkari M; Palmu A; Käyhty H;
Vaccine; 2004 Dec; 23(3):298-304. PubMed ID: 15530671
[TBL] [Abstract][Full Text] [Related]
2. Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.
Nurkka A; Lahdenkari M; Palmu AA; Käyhty H;
BMC Infect Dis; 2005 May; 5():41. PubMed ID: 15921511
[TBL] [Abstract][Full Text] [Related]
3. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
[TBL] [Abstract][Full Text] [Related]
4. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
Nurkka A; Ahman H; Korkeila M; Jäntti V; Käyhty H; Eskola J
Pediatr Infect Dis J; 2001 Jan; 20(1):25-33. PubMed ID: 11176563
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.
Bogaert D; Veenhoven RH; Ramdin R; Luijendijk IH; Rijkers GT; Sanders EA; de Groot R; Hermans PW
Vaccine; 2005 Apr; 23(20):2607-13. PubMed ID: 15780443
[TBL] [Abstract][Full Text] [Related]
6. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.
Choo S; Zhang Q; Seymour L; Akhtar S; Finn A
J Infect Dis; 2000 Oct; 182(4):1260-3. PubMed ID: 10979930
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion.
van Heerbeek N; Straetemans M; Wiertsema SP; Ingels KJ; Rijkers GT; Schilder AG; Sanders EA; Zielhuis GA
Pediatrics; 2006 Mar; 117(3):603-8. PubMed ID: 16510637
[TBL] [Abstract][Full Text] [Related]
10. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP
Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047
[TBL] [Abstract][Full Text] [Related]
12. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
[TBL] [Abstract][Full Text] [Related]
13. Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.
Ekström N; Ahman H; Verho J; Jokinen J; Väkeväinen M; Kilpi T; Käyhty H
Infect Immun; 2005 Jan; 73(1):369-77. PubMed ID: 15618174
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements.
Sarasoja I; Jokinen J; Lahdenkari M; Kilpi T; Palmu AA
Pediatr Infect Dis J; 2013 May; 32(5):517-20. PubMed ID: 23190780
[TBL] [Abstract][Full Text] [Related]
16. Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines.
Wysocki J; Tansey S; Brachet E; Baker S; Gruber W; Giardina P; Arora A
Vaccine; 2010 Nov; 28(49):7779-86. PubMed ID: 20883736
[TBL] [Abstract][Full Text] [Related]
17. Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.
O'Brien KL; Moisi J; Moulton LH; Madore D; Eick A; Reid R; Weatherholtz R; Millar E; Hu D; Hackell J; Kohberger R; Siber G; Santosham M
J Infect Dis; 2007 Jul; 196(1):104-14. PubMed ID: 17538890
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
[TBL] [Abstract][Full Text] [Related]
20. Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine.
Wuorimaa TK; Dagan R; Bailleux F; Haikala R; Ekström N; Eskola J; Yaich M; Käyhty H
Vaccine; 2005 Nov; 23(46-47):5328-32. PubMed ID: 16118028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
